Finally, to translate the work of Wang and colleagues into therapeutic approaches for AD, further study assessing the effects of improved sleep in APOE4 carriers on AD risk or AD progression in preclinical or early stages of disease is necessary. The gene discussed is APOE; the disease is Alzheimer disease.